Corrigendum to ‘Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial’ [Vaccine 36 (2018) 4278–4286]
Vaccine（2019）
关键词
recombinant zoster vaccine,pneumococcal polysaccharide vaccine,‘immunogenicity,co-administered
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要